Dexamethasone-cyclophosphamide pulse therapy in systemic lupus erythematosus
نویسندگان
چکیده
منابع مشابه
Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: a case report.
OBJECTIVE To put systemic lupus erythematosus (SLE) in remission for a prolonged period. METHODS Dexamethasone cyclophosphamide pulse (DCP) therapy was used in a 40-year-old female with SLE of 3 years' duration. DCP therapy comprises an intravenous infusion of 100 mg dexamethasone in 500 ml of 5% glucose over 1-1(1/2) hours on 3 consecutive days along with cyclophosphamide 500 mg in the same ...
متن کاملSystemic sclerosis and dexamethasone cyclophosphamide pulse therapy.
Sir, There have been quite a few instances where the physician or may be even a dermatologist (mis) advices a patient having systemic sclerosis that there is no satisfactory treatment for this disease, as has also been done in the paper Therapeutic trials for systemic sclerosis: An update by Sardana and Garg.[1] Such patients often feel frustrated and disappointed, till another dermatologist ...
متن کاملCyclophosphamide in systemic lupus erythematosus.
Cyclophosphamide has been used in systemic lupus erythematosus (SLE) (Seah, Wong, Chew, and Jayaratnam, 1966) and beneficial results have been claimed. In experimental studies, cyclophosphamide prevents the occurrence of autoimmune disease in NZB mice which are unique in that they uniformly have a form of glomerulonephritis resembling human lupus nephritis (Schwartz, 1969). The drug is known to...
متن کاملNeurobrucellosis in systemic lupus erythematosus
Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...
متن کاملIntravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
BACKGROUND Intravenous cyclophosphamide (IVCY) pulse therapy has been used for lupus nephritis since the latter half of the 1980s; it has been shown to be effective for lupus nephritis and vasculitis and has become a standard therapy for the diffuse proliferative type of lupus nephritis in adults. IVCY therapy has also come to be used in children. This paper reports the long-term outcomes of IV...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Dermatology, Venereology and Leprology
سال: 2005
ISSN: 0378-6323
DOI: 10.4103/0378-6323.13778